{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:39:12Z","timestamp":1772991552181,"version":"3.50.1"},"reference-count":75,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T00:00:00Z","timestamp":1609372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Stiftung Mitteldeutsche Kinderkrebsforschung","award":["na"],"award-info":[{"award-number":["na"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hodgkin lymphoma (HL) is neoplasia with high cure rates. However, not all patients can be cured with the current treatment. Chemo-resistance of tumor cells is one factor involved in treatment failure. In addition to its pore-forming activity on lipid bilayer membranes, the toxin melittin from bee venom is an inhibitor of several cancer-related signaling pathways. Moreover, melittin analogs have been shown to inhibit the activity of ATP binding cassette (ABC) transporters which are known to play important roles in the chemo-resistance of tumor cells. Therefore, we tested the toxicity of melittin for HL cell lines KM-H2 and L-428 and whether melittin can increase the chemo-sensitivity of cisplatin-resistant HL cells. We found high toxicity of melittin for KM-H2 and L-428 cells. In co-cultures with normal blood cells, melittin preferentially killed KM-H2 and L-428 cells. In addition, we observed increased cisplatin sensitivity of chemo-resistant L-428 cells after treatment with melittin. ABC transporter activity was not reduced after treatment with melittin. Our data suggest that melittin or melittin analogs might be promising agents for the future development of treatment strategies for HL patients with resistant disease.<\/jats:p>","DOI":"10.3390\/ijms22010343","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T10:10:37Z","timestamp":1609409437000},"page":"343","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Melittin Increases Cisplatin Sensitivity and Kills KM-H2 and L-428 Hodgkin Lymphoma Cells"],"prefix":"10.3390","volume":"22","author":[{"given":"Teresa","family":"Kreinest","sequence":"first","affiliation":[{"name":"Department of Pediatrics I, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Volkmer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics I, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3765-7068","authenticated-orcid":false,"given":"Martin S.","family":"Staege","sequence":"additional","affiliation":[{"name":"Department of Pediatrics I, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pathol.2019.09.005","article-title":"Hodgkin lymphoma: A review of pathological features and recent advances in pathogenesis","volume":"52","author":"Piris","year":"2020","journal-title":"Pathology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bienz, M., Ramdani, S., and Knecht, H. (2020). Molecular pathogenesis of Hodgkin lymphoma: Past, present, future. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186623"},{"key":"ref_3","first-page":"263","article-title":"Zur biologischen Aktivit\u00e4t des Bienengiftes Melittin","volume":"24","author":"Jentsch","year":"1969","journal-title":"Z. Nat. B"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/280072a0","article-title":"Melittin shares certain cellular effects with phorbol ester tumour promoters","volume":"280","author":"Mufson","year":"1997","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/tcm.1770010302","article-title":"Interactions between initiating chemical carcinogens, tumor promoters, and adenovirus in cell transformation","volume":"1","author":"Fisher","year":"1980","journal-title":"Teratog. Carcinog. Mutagen."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/jvi.36.2.421-428.1980","article-title":"Factors which disorganize microtubules or microfilaments increase the frequency of cell transformation by polyoma virus","volume":"36","author":"Seif","year":"1980","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0065-2571(81)90009-1","article-title":"Stimulation of Na influx, Na-K pump activity and DNA synthesis in quiescent cultured cells","volume":"19","author":"Rozengurt","year":"1980","journal-title":"Adv. Enzym. Regul."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1073\/pnas.77.3.1341","article-title":"Mepacrine blocks beta-adrenergic agonist-induced desensitization in astrocytoma cells","volume":"77","author":"Mallorga","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/exer.1998.0810","article-title":"Induction of apoptosis by arachidonic acid in human retinoblastoma Y79 cells: Involvement of oxidative stress","volume":"70","author":"Vento","year":"2000","journal-title":"Exp. Eye Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1099\/0022-1317-51-1-61","article-title":"Tumour-promoting phorbol esters inhibit DNA synthesis and enhance virus-induced interferon production in a human lymphoma cell line","volume":"51","author":"Adolf","year":"1980","journal-title":"J. Gen. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF00258116","article-title":"Inhibition of growth of leukemic cells by inhibitors of calmodulin: Phenothiazines and melittin","volume":"14","author":"Hait","year":"1985","journal-title":"Cancer Chemother. Pharm."},{"key":"ref_12","first-page":"387","article-title":"Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists","volume":"27","author":"Lazo","year":"1985","journal-title":"Mol. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0024-3205(85)90120-1","article-title":"Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin","volume":"36","author":"Lee","year":"1985","journal-title":"Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0090-8258(89)90034-6","article-title":"Inhibition of human ovarian cancer cell proliferation by calmodulin inhibitors and the possible mechanism","volume":"35","author":"Kikuchi","year":"1989","journal-title":"Gynecol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.cdd.4400627","article-title":"Complement mediated cell death is associated with DNA fragmentation","volume":"7","author":"Cragg","year":"2000","journal-title":"Cell Death Differ."},{"key":"ref_16","first-page":"2236","article-title":"Increased lethality of calmodulin antagonists and bleomycin to human bone marrow and bleomycin-resistant malignant cells","volume":"46","author":"Lazo","year":"1986","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0006-291X(86)80102-4","article-title":"Differential cytolysis of murine spleen, bone-marrow and leukemia cells by melittin reveals differences in membrane topography","volume":"139","author":"Killion","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","first-page":"52","article-title":"Different susceptibility of lung cell lines to inhibitors of tumor promotion and inducers of differentiation","volume":"5","author":"Zhu","year":"1991","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_19","first-page":"93","article-title":"A matrix metalloproteinase 2 cleavable melittin\/avidin conjugate specifically targets tumor cells in vitro and in vivo","volume":"22","author":"Holle","year":"2003","journal-title":"Int. J. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1380-2933(96)00055-3","article-title":"Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin","volume":"2","author":"Dunn","year":"1996","journal-title":"Immunotechnology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1034\/j.1399-3011.2002.21011.x","article-title":"Sequence requirements for the activity of membrane-active peptides","volume":"60","author":"Werkmeister","year":"2002","journal-title":"J. Pept. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00262-003-0457-9","article-title":"Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: In vitro and in vivo studies","volume":"53","author":"Russell","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00262-003-0460-1","article-title":"Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody","volume":"53","author":"Carter","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.2001.6558","article-title":"Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: Studies in vitro and in vivo","volume":"85","author":"Gawronska","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/A:1022169525521","article-title":"Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo","volume":"78","author":"Leuschner","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1023351819956","article-title":"A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate","volume":"79","author":"Bodek","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-2003-39787","article-title":"Targeted destruction of normal and cancer cells through lutropin\/choriogonadotropin receptors using Hecate-betaCG conjugate","volume":"111","author":"Zaleska","year":"2003","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/pros.10259","article-title":"Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors","volume":"56","author":"Leuschner","year":"2003","journal-title":"Prostate"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/153537020422900408","article-title":"Growth repression in diethylstilbestrol\/dimethylbenz[a]anthracene-induced rat mammary gland tumor using Hecate-CGbeta conjugate","volume":"229","author":"Zaleska","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"ref_30","first-page":"245","article-title":"Efficacy of lytic peptide-bound magnetite nanoparticles in destroying breast cancer cells","volume":"4","author":"Kumar","year":"2004","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/15353702-0323006-10","article-title":"Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGbeta conjugate: Functional characteristic and molecular mechanism of cell death pathway","volume":"230","author":"Bodek","year":"2005","journal-title":"Exp. Biol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1593\/neo.04751","article-title":"A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice","volume":"7","author":"Bodek","year":"2005","journal-title":"Neoplasia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mce.2005.12.056","article-title":"Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo","volume":"260\u2013262","author":"Hansel","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_34","first-page":"193","article-title":"Melittin resistance: A counterselection for ras transformation","volume":"7","author":"Sharma","year":"1992","journal-title":"Oncogene"},{"key":"ref_35","first-page":"939","article-title":"Melittin-induced hyperactivation of phospholipase A2 activity and calcium influx in ras-transformed cells","volume":"8","author":"Sharma","year":"1993","journal-title":"Oncogene"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.lfs.2006.09.024","article-title":"Phospholipase A2-independent Ca2+ entry and subsequent apoptosis induced by melittin in human MG63 osteosarcoma cells","volume":"80","author":"Chu","year":"2007","journal-title":"Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.4049\/jimmunol.155.4.2203","article-title":"Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis","volume":"155","author":"Reiter","year":"1995","journal-title":"J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1006\/bbrc.1997.8014","article-title":"Expression of antimicrobial peptides has an antitumour effect in human cells","volume":"26","author":"Winder","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/annonc\/mdi019","article-title":"Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma","volume":"16","author":"Ling","year":"2005","journal-title":"Ann. Oncol."},{"key":"ref_40","first-page":"367","article-title":"Growth arrest and apoptosis of the human hepatocellular carcinoma cell line BEL-7402 induced by melittin","volume":"29","author":"Li","year":"2006","journal-title":"Onkologie"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.4049\/jimmunol.160.12.5929","article-title":"Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells","volume":"160","author":"Wu","year":"1998","journal-title":"J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0041-0101(99)00110-5","article-title":"Melittin activates endogenous phospholipase D during cytolysis of human monocytic leukemia cells","volume":"37","author":"Saini","year":"1999","journal-title":"Toxicon"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/abbi.2001.2314","article-title":"Melittin exerts multiple effects on the release of free fatty acids from L1210 cells: Lack of selective activation of phospholipase A2 by melittin","volume":"389","author":"Lee","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.toxicon.2007.08.015","article-title":"Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells","volume":"51","author":"Moon","year":"2008","journal-title":"Toxicon"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/hep.22240","article-title":"Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway","volume":"47","author":"Liu","year":"2008","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1074\/jbc.M807191200","article-title":"Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK\/p38 and inhibiting IkappaBalpha kinase-NFkappaB","volume":"284","author":"Wang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jep.2009.12.007","article-title":"Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK\/p38 and NF-kappaB-dependent mechanisms","volume":"127","author":"Cho","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10059-010-0028-9","article-title":"Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression","volume":"29","author":"Park","year":"2010","journal-title":"Mol. Cells"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biocel.2018.05.013","article-title":"MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells","volume":"101","author":"Ke","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.exphem.2008.02.014","article-title":"Gene expression profiles of Hodgkin\u2019s lymphoma cell lines with different sensitivity to cytotoxic drugs","volume":"36","author":"Staege","year":"2008","journal-title":"Exp. Hematol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"105592","DOI":"10.1016\/j.ejps.2020.105592","article-title":"In-depth characterization of antibacterial activity of melittin against Staphylococcus aureus and use in a model of non-surgical MRSA-infected skin wounds","volume":"156","author":"Lima","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10096-019-03674-0","article-title":"Melittin: A venom-derived peptide with promising anti-viral properties","volume":"39","author":"Memariani","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3892\/or.2017.5362","article-title":"NF \u03baB inhibition is associated with OPN\/MMP 9 downregulation in cutaneous melanoma","volume":"37","author":"Guarneri","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"a000141","DOI":"10.1101\/cshperspect.a000141","article-title":"NF-kappaB as a critical link between inflammation and cancer","volume":"1","author":"Karin","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1111\/bph.14487","article-title":"Therapeutic effects of bee venom and its major component, melittin, on atopic dermatitis in vivo and in vitro","volume":"175","author":"An","year":"2018","journal-title":"Br. J. Pharm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"109276","DOI":"10.1016\/j.cbi.2020.109276","article-title":"Antiulcerogenic effect of melittin via mitigating TLR4\/TRAF6 mediated NF-kappaB and p38MAPK pathways in acetic acid-induced ulcerative colitis in mice","volume":"331","author":"Ahmedy","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijbiomac.2018.12.207","article-title":"Astragalus polysaccharide from Astragalus Melittin ameliorates inflammation via suppressing the activation of TLR-4\/NF-kappaB p65 signal pathway and protects mice from CVB3-induced virus myocarditis","volume":"126","author":"Liu","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_58","first-page":"671","article-title":"Effect of honey bee venom on lewis rats with experimental allergic encephalomyelitis, a model for multiple sclerosis","volume":"11","author":"Karimi","year":"2012","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1642-431X(12)60009-6","article-title":"Immune response to lytic peptides conjugated to a betaCG fragment in treated BALB\/C mice","volume":"8","author":"Bogacki","year":"2008","journal-title":"Reprod. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1200\/JCO.2006.10.0917","article-title":"HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin\u2019s lymphoma","volume":"25","author":"Diepstra","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11912-020-0866-3","article-title":"Advances in therapy for relapsed or refractory Hodgkin lymphoma","volume":"22","author":"Choi","year":"2020","journal-title":"Curr. Oncol. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Staege, M.S. (2015). A multi-component model of Hodgkin\u2019s lymphoma. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124614"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"9410","DOI":"10.1038\/s41598-020-66010-z","article-title":"Tumor-associated macrophages in classical Hodgkin lymphoma: Hormetic relationship to outcome","volume":"10","author":"Werner","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.95.12.7024","article-title":"The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis","volume":"95","author":"Smyth","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.tiv.2012.01.014","article-title":"P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation","volume":"26","author":"Ditte","year":"2012","journal-title":"Toxicol. Vitr."},{"key":"ref_67","first-page":"365","article-title":"Immunohistochemical detection of multidrug resistance associated P-glycoprotein in stromal cells of malignant lymphomas","volume":"32","author":"Schlaifer","year":"1990","journal-title":"Nouv. Rev. Fr. Hematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1756-9966-30-68","article-title":"Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin\u2019s Lymphoma","volume":"30","author":"Mhaidat","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4049\/jimmunol.179.1.655","article-title":"Apis mellifera venom and melittin block neither NF-kappa B-p50-DNA interactions nor the activation of NF-kappa B, instead they activate the transcription of proinflammatory genes and the release of reactive oxygen intermediates","volume":"179","author":"Stuhlmeier","year":"2007","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Alonezi, S., Tusiimire, J., Wallace, J., Dufton, M.J., Parkinson, J.A., Young, L.C., Clements, C.J., Park, J.K., Jeon, J.W., and Ferro, V.A. (2017). Metabolomic profiling of the synergistic effects of melittin in combination with cisplatin on ovarian cancer cells. Metabolites, 14.","DOI":"10.3390\/metabo7020014"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41556-020-0507-y","article-title":"Overcoming Wnt-\u03b2-catenin dependent anticancer therapy resistance in leukaemia stem cells","volume":"22","author":"Perry","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"745","DOI":"10.21873\/invivo.10990","article-title":"A model of the development of cisplatin resistance in human small cell lung cancer xenografts","volume":"30","author":"Caffrey","year":"2016","journal-title":"Vivo"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0165-4608(86)90106-8","article-title":"Cytogenetic investigations in Hodgkin\u2019s disease: I. Involvement of specific chromosomes in marker formation","volume":"20","author":"Fonatsch","year":"1986","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood.V68.1.285.285","article-title":"Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin\u2019s disease","volume":"68","author":"Kamesaki","year":"1986","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jim.2008.08.006","article-title":"Loss of detectability of Charcot-Leyden crystal protein transcripts in blood cells after treatment with dimethyl sulfoxide","volume":"339","author":"Foell","year":"2008","journal-title":"J. Immunol. Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/1\/343\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:48:15Z","timestamp":1760179695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/1\/343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["ijms22010343"],"URL":"https:\/\/doi.org\/10.3390\/ijms22010343","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,31]]}}}